insights_auto
Por que ANW subiu 51,28%?
Saiba maischevron_right
ANW:FRA
Immuron Ltd
€ 0,030
arrow_upward
+51,28%(+0,010) 1D
12 de out., 08:05:52 GMT+2 · EUR
search
Todos os ativos
| Códigos | Preço | Variação | % de variação |
|---|
insights_autoGerando os principais insights para ANW…
Abrir
€ 0,03
Alta
€ 0,03
Baixa
€ 0,03
Valor de mercado
12,20 mi
Volume médio
627,00
Volume
8,30 mil
Alto — 52 sem
€ 0,04
Baixo — 52 sem
€ 0,01
Nº de funcionários
8
Abrir
€ 0,03
Alta
€ 0,03
Baixa
€ 0,03
Valor de mercado
12,20 mi
Volume médio
627,00
Volume
8,30 mil
Alto — 52 sem
€ 0,04
Baixo — 52 sem
€ 0,01
Nº de funcionários
8
Notícias
De fontes da web e parceiros de notícias
https://www.dars.gov.et/
·
há 6 dias
Immuron (IMRN) Slips 1.83% to $1.07 as Shares Drift Toward Lower Support - MA Cross Alert
Perfil
Immuron is a biotechnology company based in Melbourne, Australia. In 2008, the company changed its name to Immuron Limited, having previously operated as Anadis Limited.
Immuron is focused on antigen-primed and dairy-derived health products. Its proprietary technologies allow for rapid development of polyclonal antibody and other proteins-based solutions for a range of diseases. The company specialises in nutraceutical, pharmaceutical and therapeutic technology products for conditions such as oral and GI mucositis, avian influenza, E. coli travellers' diarrhoea and Anthrax containment.
In 2005, Anadis signed an agreement with Quebec's Baralex Inc. and Valeo Pharma Inc. for the distribution of Travelan, a product made by Anadis for the Canadian market. Wikipedia
Sobre Immuron Ltd
CEO-
Funcionários8
Data de fundação1994
SedeBlackburn North, Vitória, Austrália
Setor-
Siteimmuron.com.au